We would like to welcome you in Amsterdam, to evaluate the progress that has been made in our understanding of the epidemiology, pathogenesis and the development of new diagnostics since the formal recognition of Entamoeba histolytica separating it from Entamoeba dispar as separate species.
Amoebiasis: formal recognition of Entamoeba histolytica and Entamoeba dispar 10 years later
We wish to enable those involved in E. histolytica research to share information obtained by genome analysis in this parasite, so as to further identify, characterize and perform functional analyses of the parasite virulence factors responsible for invasive amoebiasis. Our aim is to provide the molecular basis for development of novel strategies and approaches to advance our understanding of pathophysiology, as well as development of field applicable diagnostics, identification of novel therapeutic targets and to assist in the preparation of a vaccine. We plan to encompass the major achievements and future goals in amoebic research within the following scientific sessions.
I. Regulation of gene expression during pathogenesis
II. Cell biology and signaling pathways
III. Diagnostics, epidemiology and intervention.
We hereby invite you to present recent advances in the study of aspects of basic, clinical and epidemiological research on Entamoeba histolytica and related Entamoebae.
The workshop will take place on May 24th and 25th 2007 as a pre/side meeting of the 5th European Congress on Tropical Medicine and International Health (www.trop-amsterdam2007.com) and everyone is invited to attend both the Entamoeba workshop and the full congress. The congress website is open for submitting your abstract and application to attend the meeting. Please be aware that the amoebiasis meeting already starts in the morning of May 24th at 8.30 before the opening of the congress. The registration fee for the amoebiasis meeting includes a special dinner in the evening on May 24th.
Unfortunately, our application for funding from EMBO was unsuccessful. We have now applied for a grant from the FLU foundation to support participation of scientists from outside Europe and USA.
The Organizing Committee
Dr. Jaco J. Verweij email@example.com
Dr. Nancy Guillen firstname.lastname@example.org
Dr. David Mirelman email@example.com
Dr. William A. Petri, Jr. firstname.lastname@example.org
Dr. Egbert Tannich email@example.com